Drugs / SPYK04
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04511845 | Sep 2020 → Sep 2026 overdue | — | Chugai Pharmaceutical | Active not recruiting | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2026-09-29 | Chugai Pharmaceutical | Chugai and InxMed Enter into a Worldwide License Agreement for SPYK04, a RAF-MEK Molecular Glue chugai-pharm.co.jp ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPYK04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04511845 ↗ |